Psychiatry and Neurology, Neurology · Philadelphia, PA
NPI
1003074584
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
3900 Woodland Ave, Padrecc, #127
Philadelphia, PA, 19104
Phone (215) 823-5800
Groups this clinician bills Medicare through
Medicare paid, 2024
$99K
2,250 services
Medicare patients, 2024
579
Average age 73
Drug cost, 2024
$1.7M
3,519 prescriptions
Company payments, 2025
$1,592
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Meredith A Spindler was code 99214 (office e&m - established), 359 times for 290 patients. In total Meredith A Spindler billed 2,250 services in 29 codes, and Medicare paid $99K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 359 | 290 | $69.04 | $25K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 165 | 147 | $12.52 | $2,065 |
| 99215 Office E&M - Established | Facility | 156 | 133 | $103.07 | $16K |
| 95984 Electrical Nerve Conductivity | Facility | 156 | 38 | $34.23 | $5,340 |
| 99213 Office E&M - Established | Facility | 128 | 112 | $46.40 | $5,940 |
| 95983 Electrical Nerve Conductivity | Facility | 117 | 54 | $38.12 | $4,461 |
| 64616 Musculoskeletal | Facility | 98 | 35 | $122.53 | $12K |
| 95970 Electrical Nerve Conductivity | Facility | 76 | 61 | $12.96 | $985 |
| 95874 Musculoskeletal | Facility | 70 | 30 | $14.34 | $1,004 |
| 64642 Musculoskeletal | Facility | 58 | 23 | $73.92 | $4,288 |
| 64612 Musculoskeletal | Facility | 41 | 17 | $125.54 | $5,147 |
| 99204 Office E&M - New | Facility | 30 | 30 | $104.65 | $3,140 |
| 64611 Musculoskeletal | Facility | 28 | 14 | $87.53 | $2,451 |
| 99212 Office E&M - Established | Facility | 28 | 26 | $23.39 | $655 |
| 64643 Musculoskeletal | Facility | 27 | 11 | $57.30 | $1,547 |
By year: 2022 $108K for 2,338 services; 2023 $107K for 2,820 services; 2024 $99K for 2,250 services.
Medicare prescription drug claims, 2024
In 2024, the drug Meredith A Spindler prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 871 prescriptions and refills. In total Meredith A Spindler wrote 3,519 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 871 | 2,069 | 255 | $42K |
| Clonazepam Generic | 204 | 436 | 69 | $3,676 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 196 | 492 | 69 | $11K |
| Amantadine Amantadine Hcl | 181 | 423 | 53 | $14K |
| Rasagiline Mesylate Generic | 145 | 370 | 40 | $39K |
| Donepezil Hcl Generic | 116 | 238 | 40 | $1,523 |
| Rytary Carbidopa/Levodopa | 104 | 215 | 30 | $232K |
| Nuplazid Pimavanserin Tartrate | 88 | 110 | 16 | $539K |
| Entacapone Generic | 85 | 182 | 21 | $23K |
| Gabapentin Generic | 83 | 165 | 22 | $2,073 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 77 | 172 | 21 | $1,255 |
| Ropinirole Er Ropinirole Hcl | 70 | 204 | 15 | $15K |
| Mirtazapine Generic | 56 | 80 | 16 | $575 |
| Quetiapine Fumarate Generic | 56 | 126 | 23 | $970 |
| Primidone Generic | 50 | 116 | 17 | $1,325 |
Brand drugs: - claims; generic drugs: 3,079 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Meredith A Spindler $1,592 ($1,592 in general payments such as food, travel and fees) from 5 companies. The largest payer was Boston Scientific Corporation with $1,304.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.